M. Rother

1.4k total citations
59 papers, 1.1k citations indexed

About

M. Rother is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Neurology. According to data from OpenAlex, M. Rother has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Neurology. Recurrent topics in M. Rother's work include Inflammatory mediators and NSAID effects (8 papers), Neurological Disorders and Treatments (6 papers) and Heart Rate Variability and Autonomic Control (6 papers). M. Rother is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Neurological Disorders and Treatments (6 papers) and Heart Rate Variability and Autonomic Control (6 papers). M. Rother collaborates with scholars based in Germany, France and United States. M. Rother's co-authors include Gregor Cevc, Herbert Witte, Barbara Kittner, Philip G. Conaghan, M. Eiselt, Jan Marcusson, Ulrich Zwiener, Andreas Sprenger, Christoph Helmchen and H.-J. Möller and has published in prestigious journals such as Annals of the New York Academy of Sciences, Annals of the Rheumatic Diseases and International Journal of Pharmaceutics.

In The Last Decade

M. Rother

58 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Rother Germany 21 214 208 193 169 139 59 1.1k
Fenghua Chen China 25 28 0.1× 288 1.4× 372 1.9× 147 0.9× 59 0.4× 67 2.0k
Michele Iester Italy 32 57 0.3× 77 0.4× 179 0.9× 74 0.4× 23 0.2× 146 2.9k
Chaodong Wang China 21 34 0.2× 92 0.4× 203 1.1× 346 2.0× 51 0.4× 104 1.6k
Jiin‐Cherng Yen Taiwan 21 25 0.1× 98 0.5× 161 0.8× 137 0.8× 27 0.2× 43 1.0k
Yu‐Wen Chen Taiwan 22 63 0.3× 195 0.9× 43 0.2× 1.0k 6.1× 11 0.1× 122 1.6k
Tadashi Hashimoto Japan 19 53 0.2× 231 1.1× 38 0.2× 237 1.4× 74 0.5× 81 1.6k
Kensuke Orito Japan 20 10 0.0× 397 1.9× 268 1.4× 205 1.2× 32 0.2× 91 1.6k
Adrián L. Rabinowicz United States 27 106 0.5× 96 0.5× 59 0.3× 146 0.9× 47 0.3× 118 2.2k
Juan D. Ramirez United Kingdom 15 24 0.1× 182 0.9× 57 0.3× 811 4.8× 19 0.1× 20 1.3k
Jill C. Fehrenbacher United States 20 21 0.1× 163 0.8× 42 0.2× 600 3.6× 58 0.4× 39 1.7k

Countries citing papers authored by M. Rother

Since Specialization
Citations

This map shows the geographic impact of M. Rother's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rother with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rother more than expected).

Fields of papers citing papers by M. Rother

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rother. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rother. The network helps show where M. Rother may publish in the future.

Co-authorship network of co-authors of M. Rother

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rother. A scholar is included among the top collaborators of M. Rother based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rother. M. Rother is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nilsson, Björn M., M. Rother, Johan Bylund, et al.. (2023). Safety, Tolerability, Pharmacokinetics and Quantitative Electroencephalography Assessment of ACD856, a Novel Positive Allosteric Modulator of Trk-Receptors Following Multiple Doses in Healthy Subjects. The Journal of Prevention of Alzheimer s Disease. 10(4). 778–789. 6 indexed citations
5.
Rother, M. & Philip G. Conaghan. (2013). A Randomized, Double-blind, Phase III Trial in Moderate Osteoarthritis Knee Pain Comparing Topical Ketoprofen Gel with Ketoprofen-free Gel. The Journal of Rheumatology. 40(10). 1742–1748. 29 indexed citations
6.
Magerl, Markus, M. Rother, Thomas Bieber, et al.. (2012). Randomized, double‐blind, placebo‐controlled study of safety and efficacy of miltefosine in antihistamine‐resistant chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology. 27(3). e363–9. 22 indexed citations
8.
9.
Cevc, Gregor, et al.. (2008). Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. International Journal of Pharmaceutics. 359(1-2). 190–197. 41 indexed citations
10.
Cevc, Gregor, et al.. (2008). Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. International Journal of Pharmaceutics. 360(1-2). 29–39. 67 indexed citations
12.
Dirschedl, P., et al.. (2003). Modellprojekt Kodierqualität. Das Gesundheitswesen. 65(1). 1–7. 5 indexed citations
13.
Fesq, Heike, Jens Lehmann, M. Rother, et al.. (2003). Improved risk-benefit ratio for topical triamcinolone acetonide in TransfersomeR in comparison with equipotent cream and ointment: a randomized controlled trial. British Journal of Dermatology. 149(3). 611–619. 45 indexed citations
14.
Wimo, Anders, Elke Witthaus, M. Rother, & Bengt Winblad. (1998). Economic impact of introducing propentofylline for the treatment of dementia in Sweden. Clinical Therapeutics. 20(3). 552–566. 14 indexed citations
15.
Kittner, Barbara, et al.. (1997). Clinical Trials in Dementia with Propentofyllinea. Annals of the New York Academy of Sciences. 826(1). 307–316. 70 indexed citations
16.
Witte, Herbert & M. Rother. (1992). High-frequency and low-frequency heart-rate fluctuation analysis in newborns?A review of possibilities and limitations. Basic Research in Cardiology. 87(2). 193–204. 12 indexed citations
17.
Witte, Herbert, et al.. (1991). Using discrete Hibert transformation for interval-related calculation of the respiration rate in neonates. Medical & Biological Engineering & Computing. 29(3). 249–253. 3 indexed citations
18.
Witte, Herbert, et al.. (1991). Use of discrete Hilbert transformation for automatic spike mapping: A methodological investigation. Medical & Biological Engineering & Computing. 29(3). 242–248. 33 indexed citations
19.
Rother, M., Herbert Witte, Ulrich Zwiener, M. Eiselt, & Petra Fischer. (1989). Cardiac aliasing — a possible cause for the misinterpretation of cardiorespirographic data in neonates. Early Human Development. 20(1). 1–12. 39 indexed citations
20.
Rother, M., et al.. (1987). Differentiation of healthy newborns and newborns-at-risk by spectral analysis of heart rate fluctuations and respiratory movements. Early Human Development. 15(6). 349–363. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026